Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 9,313 full-time employees. The company went IPO on 2019-06-14. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The firm mainly conducts its business in the domestic market.
03692.HK stock price ended at $37.24 on jeudi, after dropping 1.90%
On the latest trading day Feb 12, 2026, the stock price of 03692.HK fell by 1.90%, dropping from $37.50 to $37.24. During the session, the stock saw a volatility of 4.18%, with prices oscillating between a daily low of $36.36 and a high of $37.88. On the latest trading day, the trading volume for 03692.HK rose by 1.7M shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 7.4M shares were traded, with a market value of approximately $221.4B.
Signaux Techniques de 03692.HK
Résumé des Signaux Techniques
Acheter des signaux 0
Signaux neutres 2
Signaux de vente 5
Strong Sell
Sell
Neutral
Buy
Strong Buy
03692.HK présente actuellement 0 signaux d'achat et 5 signaux de vente. L'action est en Tendance baissière depuis 12:00 AM, avec une variation totale du prix de -1.9% pendant cette période. En général, les indicateurs techniques indiquent une tendance Strong Sell à moyen terme.
Signaux haussiers/baissiers pour 03692.HK
Nous analysons les indicateurs clés comme les moyennes mobiles, le RSI, le MACD et le volume de transactions pour générer des signaux haussiers et baissiers pour 03692.HK, vous aidant à prendre des décisions d'investissement éclairées.